Home
>
National Drug Code (NDC)
>
Topamax
Topamax - 50458-642-65 - (topiramate)
Drug Information of Topamax
| Product NDC: | 50458-642 |
| Proprietary Name: | Topamax |
| Non Proprietary Name: | topiramate |
| Active Ingredient(s): | 200 mg/1 & nbsp; topiramate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Topamax
| Product NDC: | 50458-642 |
| Labeler Name: | Janssen Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020505 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19970101 |
Package Information of Topamax
| Package NDC: | 50458-642-65 |
| Package Description: | 60 TABLET, COATED in 1 BOTTLE (50458-642-65) |
NDC Information of Topamax
| NDC Code | 50458-642-65 |
| Proprietary Name | Topamax |
| Package Description | 60 TABLET, COATED in 1 BOTTLE (50458-642-65) |
| Product NDC | 50458-642 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | topiramate |
| Dosage Form Name | TABLET, COATED |
| Route Name | ORAL |
| Start Marketing Date | 19970101 |
| Marketing Category Name | NDA |
| Labeler Name | Janssen Pharmaceuticals, Inc. |
| Substance Name | TOPIRAMATE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
